CFMS - Conformis highlights cost effectiveness of its knee replacement technology

Conformis (CFMS) says that an independent, retrospective review of hospital data has concluded that its Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants.The review based on a financial database and electronic health records was independently performed at a single medical institution between 2016 and 2019 with no sponsorship or funding from Conformis, a statement from the company added.Early March, Conformis shares jumped on the Australian regulatory clearance for iTotal PS total knee replacement system.

For further details see:

Conformis highlights cost effectiveness of its knee replacement technology